Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 4/20 | 0.63 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.63 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.63 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.63 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.63 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.63 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.63 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.63 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.63 |
| ▸ | ESR1 | P03372 | 1/20 | 0.63 |
| ▸ | PGR | P06401 | 1/20 | 0.63 |
| ▸ | HTR1A | P08908 | 1/20 | 0.63 |
| ▸ | DRD1 | P21728 | 1/20 | 0.63 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.63 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.63 |
| ▸ | PDE4A | P27815 | 1/20 | 0.63 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.63 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.63 |
| ▸ | DRD3 | P35462 | 1/20 | 0.63 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL34882 | 0.87 | ACHE (0.81) | ACHECHRM2ADRA2AADORA3CHRM1 | |
| Formaldehyde SCHEMBL28001350 | 0.85 | ACHE (0.71) | ACHECHRM2ADRA2AADORA3CHRM1 | |
| SCHEMBL3188166 | 0.85 | ACHE (0.71) | ACHECHRM2ADRA2AADORA3CHRM1 | |
| SCHEMBL3188172 | 0.85 | ACHE (0.71) | ACHECHRM2ADRA2AADORA3CHRM1 | |
| Fluoride Ion SCHEMBL1502795 | 0.84 | ACHE (0.77) | ACHECHRM2ADRA2AADORA3CHRM1 | |
| Iodide SCHEMBL1502803 | 0.84 | CHRM2 (0.77) | ACHECHRM2ADRA2AADORA3CHRM1 | |
| SCHEMBL28843829 | 0.84 | ACHE (0.77) | ACHECHRM2ADRA2AADORA3CHRM1 | |
| Hydrochloric Acid SCHEMBL2696916 | 0.84 | ACHE (0.77) | ACHECHRM2ADRA2AADORA3CHRM1 | |
| Bromide SCHEMBL382846 | 0.84 | ACHE (0.82) | ACHECHRM2ADRA2AADORA3CHRM1 | |
| Bromide SCHEMBL18062500 | 0.84 | ACHE (0.82) | ACHECHRM2ADRA2AADORA3CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 690 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3337876-B1 | METHOD FOR MAKING POLYALPHAOLEFINS USING IONIC LIQUID CATALYZED OLIGOMERIZATION OF OLEFINS | CHEVRON PHILLIPS CHEMICAL CO LP (US) | 2024-06-12 | — | — | EP | claimed |
| CN-117209638-B | Amphoteric ion rare earth element alkyl catalyst and preparation method and application thereof | 传化智联股份有限公司 | 2024-02-13 | — | — | CN | claimed |
| CN-113966319-B | Synthesis of base oils by ion catalyst oligomerization and anhydrous separation of oligomerization catalysts | 雪佛龙美国公司 | 2023-12-19 | — | — | CN | claimed |
| CN-117209638-A | Amphoteric ion rare earth element alkyl catalyst and preparation method and application thereof | 传化智联股份有限公司 | 2023-12-12 | — | — | CN | claimed |
| US-11753355-B2 | Base oil synthesis via ionic catalyst oligomerization and waterless separation of the oligomerization catalyst | CHEVRON U.S.A. INC. (US) | 2023-09-12 | — | — | US | claimed |
| EP-3962883-A1 | BASE OIL SYNTHESIS VIA IONIC CATALYST OLIGOMERIZATION AND WATERLESS SEPARATION OF THE OLIGOMERIZATION CATALYST | Chevron U.S.A. Inc. (US) | 2022-03-09 | — | — | EP | claimed |
| US-20220041526-A1 | BASE OIL SYNTHESIS VIA IONIC CATALYST OLIGOMERIZATION AND WATERLESS SEPARATION OF THE OLIGOMERIZATION CATALYST | CHEVRON U.S.A. INC. | 2022-02-10 | — | — | US | claimed |
| CN-111909193-A | Phenyl trimethylsilane and preparation method thereof | 江西星火狮达科技有限公司 | 2020-11-10 | — | — | CN | claimed |
| WO-2020222168-A1 | Base Oil Synthesis via Ionic Catalyst Oligomerization and Waterless Separation of the Oligomerization Catalyst | CHEVRON U.S.A. INC. (US) | 2020-11-05 | — | — | WO | claimed |
| EP-1836285-B1 | INTEGRATED ALKYLATION PROCESS USING IONIC LIQUID CATALYSTS | CHEVRON USA INC (US) | 2019-11-20 | — | — | EP | claimed |
| US-20080146858-A1 | ISOMERIZATION OF BUTENE IN THE IONIC LIQUID-CATALYZED ALKYLATION OF LIGHT ISOPARAFFINS AND OLEFINS | CHEVRON U.S.A. INC. | 2008-06-19 | — | — | US | claimed |
| US-20080142413-A1 | ALKYLATION PROCESS USING AN ALKYL HALIDE PROMOTED IONIC LIQUID CATALYST | CHEVRON U.S.A. INC. | 2008-06-19 | — | — | US | claimed |
| CN-100374410-C | Method of preparing amide from ketoximes by Beckmann rearrangement | LANZHOU CHEM PHYS INST (CN) | 2008-03-12 | — | — | CN | claimed |
| US-20070225538-A1 | Alkylation process using an alkyl halide promoted ionic liquid catalyst | CHEVRON U.S.A. INC. | 2007-09-27 | — | — | US | claimed |
| EP-1836285-A2 | INTEGRATED ALKYLATION PROCESS USING IONIC LIQUID CATALYSTS | Chevron U.S.A. Inc. (US) | 2007-09-26 | — | — | EP | claimed |
| CN-1919833-A | Method of preparing amide from ketoximes by Beckmann rearrangement | LANZHOU CHEM PHYS INST (CN) | 2007-02-28 | — | — | CN | claimed |
| WO-2006073749-A2 | INTEGRATED ALKYLATION PROCESS USING IONIC LIQUID CATALYSTS | CHEVRON U.S.A., INC. (US) | 2006-07-13 | — | — | WO | claimed |
| WO-2006068983-A2 | ALKYLATION PROCESS USING CHLOROALUMINATE IONIC LIQUID CATALYSTS | CHEVRON U.S.A. INC. (US) | 2006-06-29 | — | — | WO | claimed |
| US-20060131209-A1 | Integrated alkylation process using ionic liquid catalysts | CHEVRON U.S.A., INC. | 2006-06-22 | — | — | US | claimed |
| US-20060135839-A1 | Alkylation process using chloroaluminate ionic liquid catalysts | CHEVERON U.S.A., INC. | 2006-06-22 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080146858-A1 | ISOMERIZATION OF BUTENE IN THE IONIC LIQUID-CATALYZED ALKYLATION OF LIGHT ISOPARAFFINS AND OLEFINS | INF2, MACF1, ILF2 | ACHE 2234/4885CHRM2 1220/4885ADRA2A 2117/4885 |
| US-20070225538-A1 | Alkylation process using an alkyl halide promoted ionic liquid catalyst | ALKBH3, ALK, L3MBTL3 | ACHE 2245/4885CHRM2 117/4885ADRA2A 2613/4885 |
| US-20060131209-A1 | Integrated alkylation process using ionic liquid catalysts | ELL, ALKBH3, INTS9 | ACHE 324/4885CHRM2 427/4885ADRA2A 3773/4885 |
| US-20060135839-A1 | Alkylation process using chloroaluminate ionic liquid catalysts | ELOB, INTS6, RTF1 | ACHE 1612/4885CHRM2 182/4885ADRA2A 3539/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.